Wyeth v. Levine, 555 U.S. 555 (2009), is a United States Supreme Court case holding that Federal regulatory clearance of a medication does not shield the ...
Mar 4, 2009 ... Petitioner Wyeth manufactures the antinausea drug Phenergan. After ... Geier v. American Honda Motor. Co., 529 U. S. 861, is distinguished.
Nov 3, 2008 ... Diana Levine filed this personal injury action against Wyeth, the drug manufacturer, in state court in Vermont. Ms. Levine had intravenously ...
Due to the significant risk associated with HSCT, including graft-versus-host disease and severe ...... I. Borggraefe, S. Koletzko, T. Arenz, et al. ..... Nestlé Nutrition, Vifor, and Wyeth and has participated in industrial project collaboration with ...
Additionally, we observed a strong functional trade-off in this mutant versus earlier classes of tetracyclines (Fig. 6b to d). Thus, the ..... Arenz S,; Nguyen F,; Beckmann R,; Wilson DN . 2015. Cryo-EM .... Wyeth Pharmaceuticals, Philadelphia, PA.
23.1%) and were in full-time employment (39.9 vs. 44.8%) ...... de Recherche Clinique AOM 05011) and by the Wyeth Foundation for Children and Adolescents.
Mar 9, 2011 ... 23.1%) and were in full-time employment (39.9 vs. 44.8%) (P. 0.0001). ...... by the Wyeth Foundation for Children and Adolescents. Data collection and .... 1960. 28. Arenz S, Nennstiel-Ratzel U, Wildner M, Dörr HG, von Kries R.
Feb 5, 2014 ... Review. Fabian Nguyen, Agata L. Starosta, Stefan Arenz, Daniel Sohmen, Alexandra Dönhöfer .... the late 1980s, Lederle (later Wyeth) reopened the tetra- ...... Burdett, V. (1993). transfer-RNA modification activity is necessary.
Mar 26, 2018 ... 2.72 (0.80, 6.25) for doxycycline, P < 0.001; 19.69 (8.07, 115.10) vs. .... Tigecycline and moxifloxacin were obtained from Wyeth ..... [CrossRef]; Nguyen F ., Starosta A. L., Arenz S., Sohmen D., Donhofer A., Wilson D. N. (2014).